Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 216

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

New Horizons in Cardioprotection: Recommendations From the 2010 National Heart, Lung, and Blood Institute Workshop

Open access
Schwartz Longacre, Lisa, Kloner, Robert A., Arai, Andrew E., Baines, Christopher P., Bolli, Roberto, Braunwald, Eugene, Downey, James, Gibbons, Raymond J., Gottlieb, Roberta A., Heusch, Gerd, Jennings, Robert B., Lefer, David J., Mentzer, Robert M., Murphy, Elizabeth, Ovize, Michel, Ping, Peipei, Przyklenk, Karin, Sack, Michael N., Vander Heide, Richard S., Vinten-Johansen, Jakob, Yellon, Derek M.·2011·Circulation

Abstract

Coronary heart disease is the largest major killer of American men and women and accounted for 1 of every 6 deaths in the United States in 2007.1 The annual incidence of myocardial infarction in the United States is estimated to be 935 000, with 610 000 new cases and 325 000 recurrent attacks. Survivors have a much higher chance of suffering from congestive heart failure, arrhythmias, and sudden cardiac death. Prognosis after an acute myocardial ischemic injury is primarily dependent on the amount of myocardium that undergoes irreversible injury.2–4 Large transmural infarcts yield a higher probability of cardiogenic shock, arrhythmias, adverse remodeling, and development of late chronic heart failure. Although it has been known since the early 1970s that the size of a myocardial infarction can be modified by various therapeutic interventions,5 early coronary artery reperfusion by fibrinolysis or percutaneous coronary intervention, including balloon angioplasty with or without stenting, remains the only established intervention capable of consistently reducing infarct size in humans. Although reperfusion has led to significant advances in patient care and reduction in hospital mortality, delays in seeking medical attention and inherent limitations in initiating fibrinolysis or percutaneous coronary intervention dictate that additional substantive improvements in morbidity and mortality can be achieved only with the development of new adjunctive therapies coupled with reperfusion. In addition, reperfusion therapy itself may induce reperfusion injury, a phenomenon that may encompass stunned myocardium, no-reflow phenomenon, and lethal myocardial cell death. If this injury could be prevented or minimized by administration of adjunctive therapy, then the net benefit of reperfusion could be enhanced. The problem of acute ischemic injury and myocardial infarction is not limited to patients with acute coronary artery syndrome. It remains a major problem in cardiac surgery as well. It is well documented that the incidence of myocardial necrosis after surgery, as determined by creatine kinase MB enzyme release and troponin levels, ranges somewhere between 40% and 60%, and, depending on its clinical definition, the incidence of myocardial infarction after coronary artery bypass graft surgery may be as high as 19%. The intermediate and long-term implications are considerable. In a recent retrospective analysis of 18 908 patients who underwent coronary artery bypass graft surgery and in whom long-term follow-up was available, it was shown that myocardial enzyme elevation within the first 24 hours of surgery was associated with increasing mortality over the course of months to years. This study confirms earlier reports that even small enzyme elevations after surgery are associated with worse long-term outcomes.4

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.111.032698

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 216

Metadata

Authors
Schwartz Longacre, L., Kloner, R. A., Arai, A. E., Baines, C. P., Bolli, R., Braunwald, E., Downey, J., Gibbons, R. J., Gottlieb, R. A., Heusch, G., Jennings, R. B., Lefer, D. J., Mentzer, R. M., Murphy, E., Ovize, M., Ping, P., Przyklenk, K., Sack, M. N., Vander Heide, R. S., Vinten-Johansen, J., & Yellon, D. M.
Venue
Circulation
Published
2011-09-06
Volume
124
Issue
10
Pages
1172-1179
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2156123275
Cited by
216
References
3
FWCI
23.41
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New Horizons in Cardioprotection: Recommendations From the 2010 National Heart, Lung, and Blood Institute Workshop. https://app.cochat.ai/papers/10.1161/circulationaha.111.032698
The paper
Schwartz Longacre, L., Kloner, R. A., Arai, A. E., Baines, C. P., Bolli, R., Braunwald, E., Downey, J., Gibbons, R. J., Gottlieb, R. A., Heusch, G., Jennings, R. B., Lefer, D. J., Mentzer, R. M., Murphy, E., Ovize, M., Ping, P., Przyklenk, K., Sack, M. N., Vander Heide, R. S., . . . Yellon, D. M. (2011). New Horizons in Cardioprotection: Recommendations From the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation. https://doi.org/10.1161/circulationaha.111.032698

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.